Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 24, 2015 3:51 AM ET

Biotechnology

Company Overview of Neovacs S.A.

Executive Profile

Miguel Sieler

Chief Executive Officer, Neovacs S.A.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
--€34,878
As of Fiscal Year 2013

Background

Mr. Miguel Sieler serves as a Venture Partner at Truffle Capital. Mr. Sieler focuses on life sciences. Mr. Sieler served as Chief Executive Officer at Neovacs S.A. since October 17, 2013 and its General Director since October 2013. He served as Chairman and Chief Executive Officer of Bayer France. Mr. Sieler served in various senior positions at Bayer Group from 1975 to 2008. He served as the Chief Executive Officer of Bayer Pharma from 1995 to 1998 and at Bayer Group ...

Corporate Headquarters

3-5, Impasse Reille
Paris, Ile-de-France 75014

France

Phone: 33 1 53 10 93 00
Fax: 33 1 53 10 93 03

Board Members Memberships

Director, Member of Audit & Accounts Committee and Member of Compensation & Appointments Committee
Director

Education

LLB
Eberhard Karls Universität Tübingen
LLB
Institut d'Etudes Politiques de Paris

Other Affiliations

Annual Compensation

Salary€26,478
Bonus€8,400
Total Annual Compensation€34,878

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation€34,878
Total Short Term Compensation€34,878
Total Calculated Compensation€34,878
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Neovacs S.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.